Eliem Therapeutics Inc (ELYM)
10.16
+1.76
(+21.04%)
USD |
NASDAQ |
May 03, 16:00
10.14
-0.02
(-0.15%)
Pre-Market: 20:00
Eliem Therapeutics Price to Book Value: 2.616 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.616 |
| May 02, 2024 | 2.161 |
| May 01, 2024 | 1.950 |
| April 30, 2024 | 1.826 |
| April 29, 2024 | 1.293 |
| April 26, 2024 | 1.025 |
| April 25, 2024 | 0.8733 |
| April 24, 2024 | 0.9429 |
| April 23, 2024 | 0.9661 |
| April 22, 2024 | 0.997 |
| April 19, 2024 | 0.9918 |
| April 18, 2024 | 1.077 |
| April 17, 2024 | 1.141 |
| April 16, 2024 | 1.175 |
| April 15, 2024 | 1.224 |
| April 12, 2024 | 1.110 |
| April 11, 2024 | 1.180 |
| April 10, 2024 | 0.6878 |
| April 09, 2024 | 0.693 |
| April 08, 2024 | 0.693 |
| April 05, 2024 | 0.6698 |
| April 04, 2024 | 0.7188 |
| April 03, 2024 | 0.7136 |
| April 02, 2024 | 0.7239 |
| April 01, 2024 | 0.7213 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.7059 |
| March 27, 2024 | 0.711 |
| March 26, 2024 | 0.6981 |
| March 25, 2024 | 0.7136 |
| March 22, 2024 | 0.7239 |
| March 21, 2024 | 0.7031 |
| March 20, 2024 | 0.7186 |
| March 19, 2024 | 0.716 |
| March 18, 2024 | 0.7237 |
| March 15, 2024 | 0.6954 |
| March 14, 2024 | 0.6928 |
| March 13, 2024 | 0.726 |
| March 12, 2024 | 0.6539 |
| March 11, 2024 | 0.722 |
| March 08, 2024 | 0.7028 |
| March 07, 2024 | 0.7272 |
| March 06, 2024 | 0.7182 |
| March 05, 2024 | 0.726 |
| March 04, 2024 | 0.7014 |
| March 01, 2024 | 0.6925 |
| February 29, 2024 | 0.7028 |
| February 28, 2024 | 0.7079 |
| February 27, 2024 | 0.7079 |
| February 26, 2024 | 0.6796 |
| February 23, 2024 | 0.6796 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4744
Minimum
Apr 26 2022
3.036
Maximum
Oct 05 2021
0.9253
Average
0.6859
Median
Dec 15 2023
Price to Book Value Benchmarks
| Alpine Immune Sciences Inc | 12.91 |
| Candel Therapeutics Inc | 20.77 |
| Cyclacel Pharmaceuticals Inc | 4.344 |
| Lipocine Inc | 1.221 |
| GlycoMimetics Inc | 3.070 |
Price to Book Value Related Metrics
| Price | 10.16 |
| Earnings Yield | -12.90% |
| Market Cap | 281.49M |